ISOLATION AND CHARACTERIZATION OF PEPTIDES FROM BLOOD SERUM OF PATIENTS WITH MULTIPLE SCLEROSIS
DOI: http://dx.doi.org/10.30970/sbi.0902.426
Abstract
In order to find novel molecular markers of multiple sclerosis we developed a scheme of oligopeptides’ isolation including their extraction from blood serum with 10 % trichloroacetic acid, followed by precipitation of soluble substances with acetone in ratio 6:1. Oligopeptides were dissolved in water and their characteristics was determined by gel filtration under HPLC conditions and thin layer chromatography. Obtained data have shown that blood serum of MS patients contains two oligopolypeptides with average molecular masses of 300–500 Da. We also studied biological activity of TCA-soluble peptides toward some eukaryotic and prokaryotic cells in comparison with phosphopeptides isolated from casein hydrolysates. It was found that TCA-soluble peptides are capable of effective inhibiting HeLa cells’ proliferation, while their inhibitory effect was expressed toward Jurkat T-cells and was not detectable toward U373 cells. The casein’s phosphopeptides were capable to stimulate proliferation of Jurkat cells and effectively inhibited growth of cells. Neither antibacterial, nor antifungal activities of these oligopeptides were detected.
Keywords
Full Text:
PDFReferences
1. Claudio L., Raine C.S., Brosnan C.F. Evidence of persistent blood-brain barrier abnormalities in chronic-progressive multiple sclerosis. Acta Neuropathol, 1995; 90: 228-238. | |
| |
2. Frischer J.M., Bramow S., Dal-Bianco A. et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain, 2009, 132: 1175-1189. | |
| |
3. Galoyan A. Neurochemistry of brain neuroendocrine immune system: signal molecules. Neurochem. Res, 2000; 25(9-10): 1343-1355. | |
| |
4. Hohlfeld R., Wekerle H. Immunological update on multiple sclerosis. Curr. Opin. Neurol, 2001; 14: 299. | |
| |
5. Jukalo V.G., Storozh L.A. Isolation of phosphopeptides from total casein fractions. Food Chemistry and Technology, 2013; 47(2): 32-40. (In Russian) | |
| |
6. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 1970; 227: 680-685 | |
| |
7. Lefranc D., Almeras L., Dubucquoi S. et al. Distortion of the Self-Reactive IgG Antibody Repertoire in Multiple Sclerosis as a New Diagnostic Tool. J. Immunol, 2004; 172: 669-678. | |
| |
8. Methods for the determination of susceptibility of bacteria to antimicrobial agents. EUCAST Definitive document. Clin. Microbiol. Infect, 1998; 4: 291-296. | |
| |
9. Pepe G., Tenore G.C., Mastrocinque R. et al. Potential Anticarcinogenic Peptides from Bovine Milk. J. Amino Acids, 2013; 2013: 1-7. | |
| |
10. Spelenberg B., Prasad S., Cabellos S. et al. Penetration of the blood-brain-barrier: enhancement of drug delivery and imaging by bacterial glycopeptides. J. Exp. Med, 1995; 182(4): 1037-1043. | |
| |
11. Weinshenker B.C. Epidemiology of multiple sclerosis. Neurol. Clin, 1996; 14: 291-308. | |
| |
12. Hancock R.E., Sahl H.G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotech, 2006, 24: 1551-1557. |
Refbacks
- There are currently no refbacks.
Copyright (c) 2015 Studia biologica
This work is licensed under a Creative Commons Attribution 4.0 International License.